According to a new report by Polaris Market Research, the global protein expression market was valued at USD 2.69 billion in 2021 and is projected to reach USD 7.90 billion by 2030, expanding at a CAGR of 13.1% over the forecast period (up from an estimated USD 2.94 billion in 2022). Growth is underpinned by rising demand for protein-based biologics, expanding proteomics research, and accelerating recombinant protein production across key end-use industries.
What Is Driving Protein Expression Market Growth?
Demand is climbing as the growing burden of chronic disorders such as cancer, cardiovascular disease, diabetes and arthritis converges with expanding biotechnology R&D investment. Manufacturers and research institutions are prioritizing recombinant protein production, pushing protein expression adoption across pharmaceutical and academic research settings. Polaris analysts note that the widening pipeline of protein-based biologics, including monoclonal antibodies and vaccines, positions the therapeutic segment for sustained double-digit growth through 2030, with pharmaceutical and biotechnology companies emerging as the largest revenue contributor and mammalian-cell-based expression posting the fastest incremental gains.
Key Trends Shaping the Protein Expression Industry
Microfluidics-Enabled Expression Analysis
Advances in microfluidics technology are giving researchers more precise ways to measure and optimize protein output at the cellular level, strengthening technology advancement across both tumorous and non-tumorous cell analysis.
Rising Regulatory and Quality Scrutiny
Stringent regulatory approval pathways for biologics are shaping product development timelines, pushing companies to invest in more robust, compliant expression platforms as part of a tightening regulatory landscape.
New Platform Launches and Strategic Collaborations
Recent moves — including WuXi Biologics' March 2025 launch of its E. coli-based EffiX expression platform and a March 2025 collaboration between Shiru and GreenLab on corn-based protein expression — reflect an active competitive landscape and growing investment in novel expression technologies.
Market Segmentation: Breaking Down the Protein Expression Market
Polaris segments the protein expression market by expression system, product, application, end-use, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.
By Expression System
The prokaryotic expression system led the market, valued for its ability to deliver large-scale recombinant protein production quickly and at lower cost. The mammalian cell segment is projected to expand at the fastest rate through 2030 as these cells are increasingly used to express large, complex recombinant proteins.
By Product
Reagents held the largest revenue share in 2021, driven by demand for transfection reagents that improve cell culture performance. The services segment is expected to grow fastest as researchers increasingly outsource gene cloning, protein expression and purification workflows to specialized providers.
Read More @ https://www.polarismarketresearch.com/industry-analysis/protein-expression-market
By Application
The therapeutic segment dominates the market, reflecting the growing role of recombinant proteins in vaccines, diagnostics and customizable protein-based treatments.
By End-Use
Pharmaceutical and biotechnological companies accounted for the largest market revenue in 2021, propelled by rising demand for therapeutic proteins such as hormones, enzymes and anticoagulants alongside the increasing cost of new drug development.
Regional Outlook: Where Is Protein Expression Growing Fastest?
North America led the market, supported by strong biosimilar pipelines, high R&D spending and the concentration of major industry players in the region. Asia Pacific is expected to post a strong CAGR through 2030, driven by growing academic research initiatives and expanding investment in protein therapeutics development.
Competitive Landscape: Leading Protein Expression Companies
Key players profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, and Life Technologies Corporation (Thermo Fisher Scientific, Inc.), who are focusing on product launches, capacity expansion and strategic partnerships to strengthen market position across the prokaryotic expression and therapeutic application segments outlined above. Recent moves include WuXi Biologics' EffiX platform launch and Thermo Fisher Scientific's expanded bioprocessing manufacturing site in Millersburg, Pennsylvania, both aimed at deepening share in North America and Asia Pacific.
Why It Matters for Buyers Evaluating Market Entry
For stakeholders researching the protein expression market, this report benchmarks market share, segment-level pricing, and forecast data — by expression system, product, application, end-use and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking mammalian-cell expression as a growth adjacency.
More Trending Latest Reports By Polaris Market Research:
U.S. Integrated Bridge Systems Market
U.S. Autonomous Underwater Vehicle Market
North America Autonomous Cars Market
Parabolic Flight Tourism Market
How Electric Bikes Are Transforming The Future of Urban Mobility?
